Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes

OIE Revue Scientifique et Technique

Volumn 20, Issue 3, 2001, Pages 741-747

  El Idrissi, A H ^a   Benkirane, A ^a   El Maadoudi, M ^b   Bouslikhane, M ^a   Berrada, J ^a   Zerouali, A ^c  

^a INSTITUT AGRONOMIQUE ET VÉTÉRINAIRE HASSAN II   (Morocco)

^b National Laboratory of Control of Medicament   (Morocco)

^c Ministry of Agriculture (MAMVA)   (Morocco)

Author keywords

Brucella melitensis; Brucellosis; RB51 vaccine; Rev. 1 vaccine; Sheep; Vaccination

Indexed keywords

BOS TAURUS; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; OVIS; OVIS ARIES;

BACTERIUM ANTIBODY; BRUCELLA VACCINE; EYE DROPS;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLOSIS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SHEEP; SHEEP DISEASE; STANDARD; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VETERINARY ABORTION;

ABORTION, VETERINARY; ANIMALS; ANTIBODIES, BACTERIAL; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; INJECTIONS, SUBCUTANEOUS; OPHTHALMIC SOLUTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SHEEP; SHEEP DISEASES; VACCINATION;

EID: 0040755062     PISSN: 02531933     EISSN: None     Source Type: Journal    
DOI: 10.20506/rst.20.3.1305     Document Type: Review

References (21)

1. Alton G.G., Jones L.M., Angus R.D. & Verger J.M. (1988). -Bacteriologic methods. In Techniques for the brucellosis laboratory. Institut National de la Recherche Agronomique, Paris, 34-60.
2. Blasco J.M. (1997). - A review of the use of B. melitensis Rev. 1 vaccine in adult sheep and goats. Prev. vet. Med., 31 (3-4), 275-283.
3. Cheville N.F., Stevens M.G., Jensen A.E., Tatum F.M. & Halling S.M. (1993). - Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. vet. Res., 54 (10), 1591-1597.
4. Cheville N.F., Olsen S.C., Jensen A.E., Stevensens M.G., Palmer M.V. & Florance A.M. (1996). - Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. vet. Res., 57 (8), 1153-1156.
5. Elberg S. (1996). - Rev. 1 Brucella melitensis vaccine. Part III. 1981-1995. Vet. Bull., 66 (12), 1193-1200.
6. Elzer PH., Enright F.M., Colby L., Hagius S.D., Walker J.V., Fatemi M.B., Kopec J.D., Beal V.C. & Schurig G.G. (1996). -Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am. J. vet. Res., 59 (12), 1575-1578.
7. Fensterbank R., Pardon P. & Marly J. (1982). - Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes. Ann. Rech. vet., 13 (4), 295-301.
8. Fensterbank R., Pardon P. & Marly J. (1985). - Vaccination of ewes by single conjunctival administration of Brucella melitensis Rev. 1 vaccine. Ann. Rech. vét., 16 (4), 351-356.
9. Garin-Bastuji B. & Trap D. (1990). - Brucelloses animales. Techniques de Laboratoire, Centre national d'études vétérinaires et alimentaires. Laboratoire central de recherches vétérinaires, Maisons-Alfort, 65-78.
10. Garin-Bastuj B. & Benkirane A. (eds) (1996). -FAO/WHO/OIE Round Table on the use of Rev. 1 vaccine in small ruminants and cattle, 21-22 September 1995, Centre national d'études vétérinaires et alimentaires (CNEVA), Maisons-Alfort. CNEVA, Maisons-Alfort, 61-107.
11. Jiménez de Bagüés M.P., Marin C.M., Blasco J.M., Moriyon I. & Gamazo C. (1992). - An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev. 1 vaccination. Vet. Microbiol., 30 (2-3), 233-241.
12. Jiménez de Bagüés M.P., Elzer P.H., Jones S.M., Blasco J.M., Enright F.M., Schurig G.G. & Winter A.J. (1994). -Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis and Brucella ovis. Infect. Immun., 62 (11), 4990-4996.
13. Lord V.R., Schurig G.G., Cherwonogrodzky J.W., Marcano M.J. & Melendez G.E. (1998). - Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am. J. vet. Res., 59 (8), 1016-1020.
14. Olsen S.C., Bricker B., Palmer M.V., Jensen A.E. & Cheville N.F. (1999). - Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy. Res. vet. Sci., 66 (2), 101-105.
15. Palmer M.V., Olsen S.C. & Cheville N.F. (1997). - Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am. J. vet. Res., 58 (5), 472-477.
16. Roop II R.M., Jeffers G., Bagchi T., Walker J., Enright F.M. & Schurig G.G. (1991). - Experimental infection of goat fetuses in utero with a stable rough mutant of B. abortus. Res. vet. Sci., 51 (2), 123-127.
17. Schurig G.G., Roop II R.M., Bagchi T., Boyle S., Buhrman D. & Sriranganathan N. (1991). - Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol., 28 (2), 171-188.
18. Stevens M.G., Hennager S.G., Olsen S.C. & Cheville N.F. (1994). - Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J. clin. Microbiol., 32 (4), 1065-1066.
19. Verger J.M., Grayon M., Zundel E., Lechopier P. & Oliver-Bernardin V. (1995). - Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Vaccine, 13 (2), 191-196.
20. Winter A.J., Schurig G.G., Boyle S.M., Sriranganathan N., Bevins J.S., Enright F.M., Elzer P.H. & Kopec J.D. (1996). -Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am. J. vet. Res., 57 (5), 677-683.
21. World Health Organization (WHO) (1998). - The development of new/improved brucellosis vaccines: report of a WHO meeting, 11-12 December 1997, Geneva. WHO, Geneva, 19-21.